{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:03:55Z","timestamp":1789776235743,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T00:00:00Z","timestamp":1483488000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12253-016-0181-3","type":"journal-article","created":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T06:38:02Z","timestamp":1483511882000},"page":"723-730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis"],"prefix":"10.1007","volume":"23","author":[{"given":"Till","family":"Pl\u00f6nes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"H\u00f6hne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"M\u00fcller-Quernheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Zissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,4]]},"reference":[{"key":"181_CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jso.1143","volume":"78","author":"N Merritt","year":"2001","unstructured":"Merritt N, Blewett CJ, Miller JD, Bennett WF, Young JE, Urschel JD (2001) Survival after conservative (palliative) management of pleural malignant mesothelioma. J Surg Oncol 78:171\u2013174","journal-title":"J Surg Oncol"},{"key":"181_CR2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1055\/s-0031-1298905","volume":"137","author":"T Ploenes","year":"2012","unstructured":"Ploenes T, Osei-Agyemang T, Nestle U, Waller CF, Passlick B (2012) Malignant pleural mesothelioma. Dtsch Med Wochenschr 137:481\u2013486","journal-title":"Dtsch Med Wochenschr"},{"key":"181_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0169-5002(01)00257-4","volume":"34","author":"GL Ceresoli","year":"2001","unstructured":"Ceresoli GL, Locati LD, Ferreri AJ, Cozzarini C, Passoni P, Melloni G, Zannini P, Bolognesi A, Villa E (2001) Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer 34:279\u2013287","journal-title":"Lung Cancer"},{"key":"181_CR4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.canlet.2011.01.009","volume":"302","author":"C Casarsa","year":"2011","unstructured":"Casarsa C, Bassani N, Ambrogi F, Zabucchi G, Boracchi P, Biganzoli E, Coradini D (2011) Epithelial-to-mesenchymal transition, cell polarity and stemness-associated features in malignant pleural mesothelioma. Cancer Lett 302:136\u2013143","journal-title":"Cancer Lett"},{"key":"181_CR5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2131","volume":"7","author":"H Peinado","year":"2007","unstructured":"Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7:415\u2013428","journal-title":"Nat Rev Cancer"},{"key":"181_CR6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-1827.2007.02080.x","volume":"57","author":"K Kushitani","year":"2007","unstructured":"Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K (2007) Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma. Pathol Int 57:190\u2013199","journal-title":"Pathol Int"},{"key":"181_CR7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ydbio.2011.05.668","volume":"356","author":"A Gise von","year":"2011","unstructured":"von Gise A, Zhou B, Honor LB, Ma Q, Petryk A, Pu WT (2011) WT1 regulates epicardial epithelial to mesenchymal transition through beta-catenin and retinoic acid signaling pathways. Dev Biol 356:421\u2013431","journal-title":"Dev Biol"},{"key":"181_CR8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/hmg\/ddh015","volume":"13","author":"JA Davies","year":"2004","unstructured":"Davies JA, Ladomery M, Hohenstein P, Michael L, Shafe A, Spraggon L, Hastie N (2004) Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation. Hum Mol Genet 13:235\u2013246","journal-title":"Hum Mol Genet"},{"key":"181_CR9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tig.2012.04.004","volume":"28","author":"YY Chau","year":"2012","unstructured":"Chau YY, Hastie ND (2012) The role of Wt1 in regulating mesenchyme in cancer, development, and tissue homeostasis. Trends Genet 28:515\u2013524","journal-title":"Trends Genet"},{"key":"181_CR10","doi-asserted-by":"crossref","unstructured":"Hohenstein P, Hastie ND (2006) The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet 15(Spec No 2):R196\u2013201","DOI":"10.1093\/hmg\/ddl196"},{"key":"181_CR11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ijc.11721","volume":"109","author":"R Koesters","year":"2004","unstructured":"Koesters R, Linnebacher M, Coy JF, Germann A, Schwitalle Y, Findeisen P, von Knebel Doeberitz M (2004) WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells. Int J Cancer 109:385\u2013392","journal-title":"Int J Cancer"},{"key":"181_CR12","first-page":"921","volume":"61","author":"DM Loeb","year":"2001","unstructured":"Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S (2001) Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res 61:921\u2013925","journal-title":"Cancer Res"},{"key":"181_CR13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.10476","volume":"100","author":"Y Oji","year":"2002","unstructured":"Oji Y, Miyoshi S, Maeda H, Hayashi S, Tamaki H, Nakatsuka S, Yao M, Takahashi E, Nakano Y, Hirabayashi H, Shintani Y, Oka Y, Tsuboi A, Hosen N, Asada M, Fujioka T, Murakami M, Kanato K, Motomura M, Kim EH, Kawakami M, Ikegame K, Ogawa H, Aozasa K, Kawase I, Sugiyama H (2002) Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer 100:297\u2013303","journal-title":"Int J Cancer"},{"key":"181_CR14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/0218492312454017","volume":"21","author":"T Ploenes","year":"2013","unstructured":"Ploenes T, Osei-Agyemang T, Krohn A, Waller CF, Duncker-Rohr V, Elze M, Passlick B (2013) Changes in lung function after surgery for mesothelioma. Asian Cardiovasc Thorac Ann 21:48\u201355","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"181_CR15","doi-asserted-by":"crossref","first-page":"e53068","DOI":"10.1371\/journal.pone.0053068","volume":"8","author":"T Ploenes","year":"2013","unstructured":"Ploenes T, Scholtes B, Krohn A, Burger M, Passlick B, Muller-Quernheim J, Zissel G (2013) CC-chemokine ligand 18 induces epithelial to mesenchymal transition in lung cancer A549 cells and elevates the invasive potential. PLoS One 8:e53068","journal-title":"PLoS One"},{"key":"181_CR16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/path.2977","volume":"226","author":"E Miller-Hodges","year":"2012","unstructured":"Miller-Hodges E, Hohenstein P (2012) WT1 in disease: shifting the epithelial-mesenchymal balance. J Pathol 226:229\u2013240","journal-title":"J Pathol"},{"key":"181_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02981935","volume":"73","author":"H Sugiyama","year":"2001","unstructured":"Sugiyama H (2001) Wilms\u2019 tumor Gene WT1: its oncogenic function and clinical application. Int J Hematol 73:177\u2013187","journal-title":"Int J Hematol"},{"key":"181_CR18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/CMR.0b013e3282efd3ae","volume":"17","author":"DE Zamora-Avila","year":"2007","unstructured":"Zamora-Avila DE, Franco-Molina MA, Trejo-Avila LM, Rodriguez-Padilla C, Resendez-Perez D, Zapata-Benavides P (2007) RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line. Melanoma Res 17:341\u2013348","journal-title":"Melanoma Res"},{"key":"181_CR19","first-page":"4887","volume":"29","author":"S Dohi","year":"2009","unstructured":"Dohi S, Ohno S, Ohno Y, Soma G, Kyo S, Inoue M (2009) Correlation between WT1 expression and cell proliferation in endometrial cancer. Anticancer Res 29:4887\u20134891","journal-title":"Anticancer Res"},{"key":"181_CR20","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1158\/0008-5472.CAN-06-1172","volume":"66","author":"Y Rong","year":"2006","unstructured":"Rong Y, Cheng L, Ning H, Zou J, Zhang Y, Xu F, Liu L, Chang Z, Fu XY (2006) Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor. Cancer Res 66:8049\u20138057","journal-title":"Cancer Res"},{"key":"181_CR21","first-page":"5386","volume":"55","author":"SM Hewitt","year":"1995","unstructured":"Hewitt SM, Hamada S, McDonnell TJ, Rauscher FJ 3rd, Saunders GF (1995) Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res 55:5386\u20135389","journal-title":"Cancer Res"},{"key":"181_CR22","first-page":"1429","volume":"57","author":"C Englert","year":"1997","unstructured":"Englert C, Maheswaran S, Garvin AJ, Kreidberg J, Haber DA (1997) Induction of p21 by the Wilms' tumor suppressor gene WT1. Cancer Res 57:1429\u20131434","journal-title":"Cancer Res"},{"key":"181_CR23","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1093\/emboj\/18.14.3990","volume":"18","author":"MW Mayo","year":"1999","unstructured":"Mayo MW, Wang CY, Drouin SS, Madrid LV, Marshall AF, Reed JC, Weissman BE, Baldwin AS (1999) WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. EMBO J 18:3990\u20134003","journal-title":"EMBO J"},{"key":"181_CR24","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V84.9.3071.3071","volume":"84","author":"K Inoue","year":"1994","unstructured":"Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K et al (1994) WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84:3071\u20133079","journal-title":"Blood"},{"key":"181_CR25","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood.V90.3.1217","volume":"90","author":"L Bergmann","year":"1997","unstructured":"Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E, Hoelzer D (1997) High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 90:1217\u20131225","journal-title":"Blood"},{"key":"181_CR26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11060-010-0374-7","volume":"103","author":"MY Chen","year":"2011","unstructured":"Chen MY, Clark AJ, Chan DC, Ware JL, Holt SE, Chidambaram A, Fillmore HL, Broaddus WC (2011) Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression. J Neuro-Oncol 103:87\u2013102","journal-title":"J Neuro-Oncol"},{"key":"181_CR27","first-page":"751","volume":"3","author":"P Zapata-Benavides","year":"2012","unstructured":"Zapata-Benavides P, Manilla-Munoz E, Zamora-Avila DE, Saavedra-Alonso S, Franco-Molina MA, Trejo-Avila LM, Davalos-Aranda G, Rodriguez-Padilla C (2012) WT1 silencing by RNAi synergizes with chemotherapeutic agents and induces chemosensitization to doxorubicin and cisplatin in B16F10 murine melanoma cells. Oncol Lett 3:751\u2013755","journal-title":"Oncol Lett"},{"key":"181_CR28","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/cncr.23341","volume":"112","author":"MV Barbolina","year":"2008","unstructured":"Barbolina MV, Adley BP, Shea LD, Stack MS (2008) Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion. Cancer 112:1632\u20131641","journal-title":"Cancer"},{"key":"181_CR29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1349-7006.2006.00169.x","volume":"97","author":"T Jomgeow","year":"2006","unstructured":"Jomgeow T, Oji Y, Tsuji N, Ikeda Y, Ito K, Tsuda A, Nakazawa T, Tatsumi N, Sakaguchi N, Takashima S, Shirakata T, Nishida S, Hosen N, Kawakami M, Tsuboi A, Oka Y, Itoh K, Sugiyama H (2006) Wilms' tumor gene WT1 17AA(\u2212)\/KTS(\u2212) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci 97:259\u2013270","journal-title":"Cancer Sci"},{"key":"181_CR30","first-page":"3575","volume":"23","author":"TF Zhang","year":"2003","unstructured":"Zhang TF, Yu SQ, Guan LS, Wang ZY (2003) Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin. Anticancer Res 23:3575\u20133584","journal-title":"Anticancer Res"},{"key":"181_CR31","first-page":"6288","volume":"60","author":"S Maiti","year":"2000","unstructured":"Maiti S, Alam R, Amos CI, Huff V (2000) Frequent association of beta-catenin and WT1 mutations in Wilms tumors. Cancer Res 60:6288\u20136292","journal-title":"Cancer Res"},{"key":"181_CR32","doi-asserted-by":"crossref","first-page":"31930","DOI":"10.1074\/jbc.M602668200","volume":"281","author":"KM Kirschner","year":"2006","unstructured":"Kirschner KM, Wagner N, Wagner KD, Wellmann S, Scholz H (2006) The Wilms tumor suppressor Wt1 promotes cell adhesion through transcriptional activation of the alpha4integrin gene. J Biol Chem 281:31930\u201331939","journal-title":"J Biol Chem"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-016-0181-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-016-0181-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-016-0181-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T13:09:25Z","timestamp":1601298565000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-016-0181-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["181"],"URL":"https:\/\/doi.org\/10.1007\/s12253-016-0181-3","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,4]]}}}